Center for Molecular Medicine Cologne

Prof. Dr. med. H Christian Reinhardt - Curriculum Vitae

Education and Professional Career

2020: Co-founder of CDL Therapeutics GmbH
since 2020: Professor for Internal Medicine, Hematology and Stem Cell Transplantation (W3), University Hospital Essen
since 2020: Director Clinic for Hematology and Stem Cell Transplantation, University Hospital Essen
since 2020: Elected member of the board of the Competence Network Malignant Lymphoma
since 2019: Elected member of the certification committee of the German Cancer Society (Zertifizierungskommission der Deutschen Krebsgesellschaft) for hematological malignancies
since 2019: Elected Vice-Speaker of the network of Mildred Scheel Schools of Oncology (Hamburg, Würzburg, Dresden, Frankfurt, Köln-Bonn)
since 2019: Co-Speaker Collaborative Research Center "Mechanisms of Drug Sensitivity and Resistance in Small Cell Lung Cancer" (SFB-1399)
since 2018: Member of the Expert Pool of the National Committee on Animal Welfare (TierSchG) within the Federal Institute of Risk Assessment (Bundesinstitut für Risikobewertung)
2018 - 2020: Speaker of the Mildred Scheel School of Oncology: Cancer- and Immuno-genomics
2017 - 2020: Speaker of Else Kröner Forschungskolleg "Clonal Evolution in Cancer"
2015 - 2020: Attending physician (Oberarzt), Department of Internal Medicine I
2015: Board exam, certified in general internal medicine, hematology / oncology
2015 - 2020: elected member of the executive board, Center for Molecular Medicine Cologne CMMC
2013 - 2020: Head of the Clinical Research Unit 286 ‘Exploiting defects in the DNA damage response for the treatment of chronic lymphocytic leukemia’
2012 - 2020: Professor for Clinical and Molecular Oncology, University of Cologne
2012 - 2016: Scientific coordinator of Research Area C (DNA damage response) within the Excellence Cluster CECAD
2012 - 2015: Elected member of the steering committee of the Helmholtz Alliance Preclinical Comprehensive Cancer Center (PCCC) and scientific coordinator of Research Topic 3, Hematological Malignancies within the PCCC
2009 - 2015: Emmy-Noether research group leader, Max-Planck-Institute Cologne and Department of Internal Medicine I, University of Cologne
2008: ‘Habilitation’ Molecular Medicine, Medical Faculty, University of Cologne
2004 - 2009: Postdoctoral Associate, MIT, Department of Biology, Koch Institute, Advisors: Profs. M.B. Yaffe, MD, PhD and T. Jacks, PhD
2004: Postdoctoral Research Fellow, University of Münster, Advisor: Prof. Dr. H. Pavenstädt
2003: Postdoctoral Research Fellow, University of Freiburg, Advisor: Prof. Dr. G. Walz and Dr. T. Benzing
1999 - 2003: MD thesis, Department of Internal Medicine, Division 4, University of Freiburg. Entitled: Expression of functional CC- and CXC chemokine receptors in podocytes. Advisor: Prof. Dr. H. Pavenstädt (Grade: Summa cum laude, highest honors)
1996 - 2003: Medical school, (Final grade: Sehr gut, highest honors), University of Hamburg, Germany; Humboldt University, Berlin, Germany; University of Freiburg, Germany

Awards and Distinctions

2017: Gilead Research Award Oncology
2016: Theodor Frerichs Award of the German Society for Internal Medicine
2012: GlaxoSmithKline Research Award
2011: Vincenz Czerny Award of the German Society for Hematology and Oncology
2011: W2 Lichtenberg Professorship, VolkswagenStiftung
2011: CESAR Research Award of the Central European Society for Anticancer Drug Research
2011: Johann-Georg-Zimmermann Award for Cancer Research
2010: Young Leaders in Science Award, Schering Stiftung
2009: Emmy-Noether fellowship of the Deutsche Forschungsgemeinschaft
2009: Startup grant, Ministry of Innovation, Science, Research and Technology of the State of North Rhine-Westphalia
2009: NIH / NCI K99 / R00 PI award (relinquished due to return to Germany)
2009: Travel grant of the Deutsche Krebshilfe
2007: MIT-Koch Award
2005: Research fellowship of the Deutsche Forschungsgemeinschaft
2004: Young investigator award of the Deutsche Nierenstiftung


Link to PubMed